Risk Factors for HIV, Viral Hepatitis, and Syphilis among Heroin Users in Northern Taiwan

REFERENCES

• Abbas, Z., Jafri, W., & Raza, S. (2010). Hepatitis D: Scenario in the Asia-Pacific region. World Journal of Gastroenterology, 16(5), 554–562.
   PubMedGoogle Scholar
• Amirkhanian, Y. A. (2012). Review of HIV vulnerability and condom use in central and eastern Europe. Sexual Health, 9(1), 34–43.
   PubMedGoogle Scholar
• Bao, Y. P., Du, C., Lu, H. Y., Lian, Z., Qiu, Y., Mu, Y., (2012). The investigation of HIV and HCV infection and risk factors among opiate drug users in Beijing, China. The American Journal of Drug and Alcohol Abuse, 38(2), 140–145.
   PubMed Web of Science ®Google Scholar
• Bao, Y. P., & Liu, Z. M. (2009). Systematic review of HIV and HCV infection among drug users in China. International Journal of STD & AIDS, 20(6), 399–405.
   PubMed Web of Science ®Google Scholar
• Baumbach, J. P., Foster, L. N., Mueller, M., Cruz, M. F., Arbona, S., Melville, S., (2008). Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States-Mexico border. Harm Reduction Journal, 5, 33.
   PubMedGoogle Scholar
• Bialek, S. R., Bower, W. A., Mottram, K., Purchase, D., Nakano, T., Nainan, O., (2005). Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users. Journal of Urban Health, 82(3), 468–478.
   PubMed Web of Science ®Google Scholar
• Campos, L. N., Guimaraes, M. D., Carmo, R. A., Melo, A. P., Oliveira, H. N., Elkington, K., (2008). HIV, syphilis, and hepatitis B and C prevalence among patients with mental illness: A review of the literature. Cad Saude Publica, 24(Suppl.4), s607–s620.
   PubMedGoogle Scholar
• Centers for Disease Control (2011). CDC Annual Report 2011. ISSN: 1813-3428 (29–31). Taipei: Department of Health, R.O.C (Taiwan).
   Google Scholar
• Chamla, D., Chamla, J. H., Dabin, W., Delin, H., & Rennes, N. (2006). Transition to injection and sharing of needles/syringes: Potential for HIV transmission among heroin users in Chengdu, China. Addictive Behaviors, 31(4), 697–701.
   PubMedGoogle Scholar
• Chang, S. Y., Yang, C. L., Ko, W. S., Liu, W. C., Lin, C. Y., Wu, C. H., (2011). Molecular epidemiology of hepatitis D virus infection among injecting drug users with and without human immunodeficiency virus infection in Taiwan. Journal of Clinical Microbiology, 49(3), 1083–1089.
   PubMedGoogle Scholar
• Chu, F. Y., Chiang, S. C., Su, F. H., Chang, Y. Y., & Cheng, S. H. (2009). Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan. Journal of Medical Virology, 81(6), 973–978.
   PubMedGoogle Scholar
• Diekema, D. S. (2012). Improving childhood vaccination rates. The New England Journal of Medicine, 366(5), 391–393.
   PubMedGoogle Scholar
• Du, W. J., Xiang, Y. T., Wang, Z. M., Chi, Y., Zheng, Y., Luo, X. N., (2008). Socio-demographic and clinical characteristics of 3129 heroin users in the first methadone maintenance treatment clinic in China. Drug and Alcohol Dependence, 94(1–3), 158–164.
   PubMed Web of Science ®Google Scholar
• Go, V. F., Frangakis, C., Nam le, V., Bergenstrom, A., Sripaipan, T., Zenilman, J. M., (2006). High HIV sexual risk behaviors and sexually transmitted disease prevalence among injection drug users in Northern Vietnam: Implications for a generalized HIV epidemic. Journal of Acquired Immune Deficiency Syndromes, 42(1), 108–115.
   PubMed Web of Science ®Google Scholar
• Goller, J. L., Guy, R. J., Gold, J., Lim, M. S., El-Hayek, C., Stoove, M. A., (2010). Establishing a linked sentinel surveillance system for blood-borne viruses and sexually transmissible infections: Methods, system attributes and early findings. Sex Health, 7(4), 425–433.
   PubMedGoogle Scholar
• Hernandez, M. D., & Sherman, K. E. (2011). HIV/hepatitis C coinfection natural history and disease progression. Current Opinion in HIV and AIDS, 6(6), 478–482.
   PubMed Web of Science ®Google Scholar
• Kao, J. H. (2003). Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan. Intervirology, 46(6), 400–407.
   PubMed Web of Science ®Google Scholar
• Ko, N. Y., Hsu, S. T., Chen, C. H., Lee, H. C., & Ko, W. C. (2011). Heroin dependence and bloodborne virus transmission behaviors for HIV infection among newly incarcerated injection drug users in Taiwan. Substance Use & Misuse, 46(5), 591–598.
   PubMed Web of Science ®Google Scholar
• Lee, H. C., Ko, N. Y., Lee, N. Y., Chang, C. M., & Ko, W. C. (2008). Seroprevalence of viral hepatitis and sexually transmitted disease among adults with recently diagnosed HIV infection in Southern Taiwan, 2000–2005: Upsurge in hepatitis C virus infections among injection drug users. Journal of the Formosan Medical Association, 107(5), 404–411.
   PubMedGoogle Scholar
• Lee, T. S., Shen, H. C., Wu, W. H., Huang, C. W., Yen, M. Y., Wang, B. E., (2011). Clinical characteristics and risk behavior as a function of HIV status among heroin users enrolled in methadone treatment in northern Taiwan. Substance Abuse Treatment, Prevention, and Policy, 6, 6.
   PubMedGoogle Scholar
• Li, Y., Zhang, T., Douglas, S. D., Lai, J. P., Xiao, W. D., Pleasure, D. E., (2003). Morphine enhances hepatitis C virus (HCV) replicon expression. The American Journal of Pathology, 163(3), 1167–1175.
   PubMedGoogle Scholar
• Lopez-Zetina, J., Ford, W., Weber, M., Barna, S., Woerhle, T., Kerndt, P., (2000). Predictors of syphilis seroreactivity and prevalence of HIV among street recruited injection drug users in Los Angeles County, 1994–6. Sexually Transmitted Infections, 76(6), 462–469.
   PubMed Web of Science ®Google Scholar
• Mahanta, J., Medhi, G. K., Paranjape, R. S., Roy, N., Kohli, A., Akoijam, B. S., (2008). Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India. AIDS, 22(Suppl.5), S59–S68.
   PubMedGoogle Scholar
• Mathers, B. M., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M., Strathdee, S. A., (2008). Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. Lancet, 372(9651), 1733–1745.
   PubMed Web of Science ®Google Scholar
• Nasir, A., Todd, C. S., Stanekzai, M. R., Bautista, C. T., Botros, B. A., Scott, P. T., (2011). Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities. International Journal of Drug Policy, 22(2), 145–152.
   PubMedGoogle Scholar
• Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., (2011). Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews. Lancet, 378(9791), 571–583.
   PubMed Web of Science ®Google Scholar
• Ni, Y. H., & Chen, D. S. (2010). Hepatitis B vaccination in children: The Taiwan experience. Pathology Biology (Paris), 58(4), 296–300.
   PubMedGoogle Scholar
• Novak, S. P., & Kral, A. H. (2011). Comparing injection and non-injection routes of administration for heroin, methamphetamine, and cocaine users in the United States. Journal of Addictive Diseases, 30(3), 248–257.
   PubMed Web of Science ®Google Scholar
• Plitt, S. S., Sherman, S. G., Strathdee, S. A., & Taha, T. E. (2005). Herpes simplex virus 2 and syphilis among young drug users in Baltimore, Maryland. Sexually Transmitted Infections, 81(3), 248–253.
   PubMedGoogle Scholar
• Rizzetto, M., Canese, M. G., Gerin, J. L., London, W. T., Sly, D. L., & Purcell, R. H. (1980). Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. The Journal of Infectious Diseases, 141(5), 590–602.
   PubMed Web of Science ®Google Scholar
• Rondinelli, A. J., Ouellet, L. J., Strathdee, S. A., Latka, M. H., Hudson, S. M., Hagan, H., (2009). Young adult injection drug users in the United States continue to practice HIV risk behaviors. Drug and Alcohol Dependence, 104(1–2), 167–174.
   PubMed Web of Science ®Google Scholar
• Smit, C., van den Berg, C., Geskus, R., Berkhout, B., Coutinho, R., & Prins, M. (2008). Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: A 20-year prospective study. Journal of Acquired Immune Deficiency Syndromes, 47(2), 221–225.
   PubMed Web of Science ®Google Scholar
• Su, W. J., Liu, C. C., Liu, D. P., Chen, S. F., Huang, J. J., Chan, T. C., (2012). Effect of age on the incidence of acute hepatitis B after 25 years of a universal newborn hepatitis B immunization program in taiwan. The Journal of Infectious Diseases, 205(5), 757–762.
   PubMed Web of Science ®Google Scholar
• Sulkowski, M. S. (2008). Viral hepatitis and HIV coinfection. Journal of Hepatology, 48(2), 353–367.
   PubMed Web of Science ®Google Scholar
• Sulkowski, M. S. (2012). Hepatitis C virus-human immunodeficiency virus coinfection. Liver International, 32(Suppl. 1), 129–134.
   PubMedGoogle Scholar
• Te, H. S., & Jensen, D. M. (2010). Epidemiology of hepatitis B and C viruses: A global overview. Clinics in Liver Disease, 14(1), 1–21; vii.
   PubMedGoogle Scholar
• Tran, T. M., Nguyen, H. T., Yatsuya, H., Hamajima, N., Nishimura, A., & Ito, K. (2006). HIV prevalence and factorsassociated with HIV infection among male injection drug users under 30: A cross-sectional study in Long An, Vietnam. BMC Public Health, 6, 248.
   PubMed Web of Science ®Google Scholar
• Vallejo, F., Toro, C., de la Fuente, L., Brugal, M. T., Soriano, V., Silva, T. C., (2008). Prevalence of and risk factors for hepatitis B virus infection among street-recruited young injection and non-injection heroin users in Barcelona, Madrid and Seville. European Addiction Research, 14(3), 116–124.
   PubMedGoogle Scholar
• Van Herck, K., & Van Damme, P. (2008). Benefits of early hepatitis B immunization programs for newborns and infants. The Pediatric Infectious Disease Journal, 27(10), 861–869.
   PubMedGoogle Scholar
• Vickerman, P., Hickman, M., May, M., Kretzschmar, M., & Wiessing, L. (2010). Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis. Addiction, 105(2), 311–318.
   PubMed Web of Science ®Google Scholar
• Wang, X., Zhang, T., & Ho, W. Z. (2011). Opioids and HIV/HCV infection. Journal of NeuroImmune Pharmacology, 6(4), 477–489.
   PubMed Web of Science ®Google Scholar